Besides, inhibiting NLRP3/caspase-1-mediated pyroptosis attenuates pathological changes in diabetic kidneys (Wang and Zhao 2021), suggesting its therapeutic potential in DN. This evidence concerns the gene CASP1 and liver dysplastic nodule.